Credit Suisse’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $687K | Hold |
82,750
| – | – | ﹤0.01% | 2478 |
|
|
2023
Q4 | $911K | Sell |
82,750
-6,246
| -7% | -$68.8K | ﹤0.01% | 2388 |
|
|
2023
Q3 | $748K | Sell |
88,996
-29,573
| -25% | -$249K | ﹤0.01% | 2460 |
|
|
2023
Q2 | $1.49M | Buy |
118,569
+37,107
| +46% | +$466K | ﹤0.01% | 2110 |
|
|
2023
Q1 | $1.34M | Buy |
81,462
+5,346
| +7% | +$88K | ﹤0.01% | 2114 |
|
|
2022
Q4 | $1.14M | Buy |
76,116
+11,608
| +18% | +$173K | ﹤0.01% | 2237 |
|
|
2022
Q3 | $1.44M | Buy |
64,508
+6,497
| +11% | +$145K | ﹤0.01% | 2045 |
|
|
2022
Q2 | $971K | Buy |
58,011
+25,033
| +76% | +$419K | ﹤0.01% | 2393 |
|
|
2022
Q1 | $987K | Buy |
32,978
+2,760
| +9% | +$82.6K | ﹤0.01% | 2545 |
|
|
2021
Q4 | $928K | Sell |
30,218
-2,643
| -8% | -$81.2K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $1.04M | Sell |
32,861
-974
| -3% | -$30.7K | ﹤0.01% | 2559 |
|
|
2021
Q2 | $1.24M | Buy |
33,835
+4,521
| +15% | +$166K | ﹤0.01% | 2490 |
|
|
2021
Q1 | $1.01M | Sell |
29,314
-21,909
| -43% | -$757K | ﹤0.01% | 2571 |
|
|
2020
Q4 | $2.13M | Buy |
+51,223
| New | +$2.13M | ﹤0.01% | 2091 |
|